News

The Lyme ImmunoBlot test first introduced by IGeneX in 2017 has been augmented. Now converted to a test kit, it has received FDA clearance. The name of the test is iDart™ Lyme IgG ImmunoBlot Kit. It’s a stand-alone test for the detection of IgG antibodies against... Read More »

A Celebration of Life for Pat Smith will be held September 7 in Neptune, New Jersey. For people who can’t make it in person, it will also be livestreamed via Zoom. Smith, founder and longtime president of the national Lyme Disease Association (LDA), died on August 17. Click... Read More »

By Wayne Lewis, UCLA For some unlucky people, time in the great outdoors leads to Lyme disease, an illness causing head, joint and muscle pain, flu-like symptoms, fatigue, and sometimes a rash. Left untreated, those effects can turn debilitating and expand to include paralysis,... Read More »

The LymeX Diagnostics Prize has announced that both Labcorp and Quest Diagnostics will serve as industry supporters of the LymeX competition. Labcorp and Quest Diagnostics will provide non-financial in-kind support, helping Phase 3 teams deepen their understanding of the... Read More »

By Jim Lynch, University of Michigan Nanoparticles delivered intravenously in mice can block the allergic reactions to red meat caused by the bite of the lone star tick, research led by the University of Michigan shows. The condition, called alpha-gal syndrome, is on the rise in... Read More »

While Lyme disease is the most recognized and prevalent tick-borne disease in the United States, other infections transmitted through tick bites can be equally or even more dangerous. One of these is the Powassan virus (POWV). Erich Mackow, PhD, an internationally recognized... Read More »

A Celebration of Life for Pat Smith will be held September 7 in Neptune, New Jersey. It will also be livestreamed. Click here for details. From the Lyme Disease Association website: It is with deep sadness and a profound sense of loss that we share the news of the passing of our... Read More »

The California State Board of Pharmacy (BOP) is expected to block access to an entire class of alternative treatments including IV glutathione and methylcobalamin (a form of vitamin B12). These are relied on by many people with persistent Lyme disease and other chronic illnesses,... Read More »

On September 12, the California State Board of Pharmacy is expected to vote to eliminate access to safe and critical Category 1 substances like methylcobalamin (a form of vitamin B12) and glutathione infusions. These are relied upon by some of California’s most vulnerable... Read More »